ESG emerging as equity market driver

MALAYSIA’S equity market is set to see capital rotate more decisively towards companies that can prove their environmental, social and governance (ESG) credentials, as sustainability metrics shift from peripheral disclosures to core valuation drivers.

According to BIMB Research, global investment strategies now pivot on the ESG criteria, placing healthcare and consumer sectors under the microscope.

In Malaysia, the brokerage notes, this shift is intensified by an ageing population, rising chronic diseases and a middle class increasingly concerned about food security and plastic waste.

It says local companies must navigate rising healthcare costs and evolving consumer habits by balancing profitability with social equity and sustainable practices.

The FTSE4Good Bursa Malaysia Index (F4GBM) serves as the primary benchmark for this transition, evaluating public companies against more than 300 ESG indicators ranging from labour standards to climate stewardship.

Inclusion in the index acts as a critical signal to institutional investors, validating a company’s commitment to transparent governance.

“Strong ESG credentials are no longer just ‘nice to have’ – they are essential for attracting sustainability-linked capital in a competitive global market,” BIMB Research points out.

It observes that within F4GBM, healthcare and consumer giants are demonstrating that sustainability extends beyond public relations.

For instance, it notes that IHH Healthcare Bhd prioritises patient safety and medical access, while Nestle Malaysia Bhd steps up efforts to tackle plastic waste and supply chain emissions.

“These are strategic responses to a global investment landscape that now treats long-term environmental and social risks as core financial indicators,” BIMB Research says.

Key differentiator

For institutional investors, ESG performance is becoming a primary differentiator.

Leaders in health equity and sustainable consumption enjoy enhanced brand equity and access to sustainability-linked financing, whereas laggards face what BIMB Research describes as a “grim cocktail of regulatory penalties and market share erosion”.

It adds that ESG has graduated from a “check-the-box” compliance chore to a high-stakes competitive advantage.

In the consumer sector, companies face mounting pressure to embrace sustainable consumption and circular economy practices.

Regulators and investors demand reductions in packaging waste, responsible marketing, and healthier product portfolios.

The European Union single-use plastics directive, under the Circular Economy Action Plan, has become a global benchmark influencing standards in developed and emerging markets alike.

At the same time, rising obesity rates intensify scrutiny of nutrition and product composition.

The World Health Organisation projects that diet-related non-communicable diseases, including diabetes and cardiovascular disease, will account for more than 70% of global deaths by 2030.

Multinationals such as Nestle and Unilever have responded with ambitious sustainability pledges.

Nestle commits to making 100% of its packaging recyclable or reusable by 2025 and achieving net-zero emissions by 2050, although independent assessments flag challenges in meeting these targets.

“Such commitments influence investor sentiment and set expectations for greater transparency and accountability across global subsidiaries (including Malaysian operations),” BIMB Research asserts.

Healthcare’s ESG focus, meanwhile, centres on equity, access and sustainability.

Stark disparities persist in healthcare delivery between urban and rural communities and between higher and lower-income economies.

The Covid-19 pandemic underscores the vulnerability of health systems and reinforces calls for universal health coverage.

Private providers are increasingly evaluated on their ability to balance profitability with affordability, patient safety and fair labour practices.

Sustainability challenges in healthcare supply chains – from pharmaceutical emissions to medical waste and hospital carbon footprints – also draw investor attention.

“In advanced markets, investors push providers to disclose climate risks and resilience strategies in line with frameworks like the Task Force on Climate-related Financial Disclosures and the International Sustainability Standards Board,” BIMB Research says.

Widening gap

For Malaysia’s public-listed companies, the convergence of health equity and sustainable consumption is not merely reputational – it is a material business and investment consideration, BIMB Research stresses.

It points out that constituents of F4GBM in healthcare and consumer sectors face growing pressure from investors, regulators and consumers to demonstrate measurable ESG progress.

“Those that lead in inclusivity, sustainability and transparency are better positioned to capture long-term growth and access sustainability-linked financing, while laggards face the risk of index exclusion, reputational damage and investor divestment,” BIMB Research highlights.

It notes that the gap between ESG leaders and laggards is widening due to finance-grade reporting requirements.

Bursa Malaysia’s alignment with the International Sustainability Standards Board means sustainability data is treated with the same legal and audit rigour as financial statements.

Under what it terms “The Winners (Alpha Capture)”, companies that successfully integrate Scope 3 supply chain transparency and health equity initiatives – such as affordable healthcare access or nutritious product portfolios – are seeing a lower cost of equity.

These “frontrunners” are increasingly favoured by institutional investors with ESG mandates.

Conversely, under “The Losers (Capital Flight)”, companies that treat ESG as a “checkbox” exercise face valuation discounts.

As Malaysia introduces its carbon tax in 2026, initially targeting energy and heavy industries, carbon-intensive laggards without a clear transition roadmap are seeing institutional investors “filter” them out of core portfolios to avoid stranded asset risks.

Specifically in the healthcare and consumer segments, ESG is shifting from “risk mitigation” to a top-line growth driver, BIMB Research points out.

On health equity, beyond clinical outcomes, investors assess how providers address the underserved B40 community.

Companies leading in digital health accessibility and transparent drug pricing secure what BIMB Research calls “Social” (S) pillar premiums.

In sustainable consumption, packaging milestones in 2025 and 2026 become a defining test for fast-moving consumer goods players.

Investors signal that circularity is a proxy for operational efficiency.

Companies able to reduce virgin plastic use while maintaining margins demonstrate what the research house terms “Resilience Alpha”, positioning themselves at the intersection of compliance, competitiveness, and capital attraction in Malaysia’s evolving ESG landscape.